Is there gluten in prescription drugs?

Most prescription drugs in the United States are gluten-free. Roughly 1–2% of common adult oral drugs contain any gluten at all, and when present it is usually well below the 10 mg/day threshold generally considered safe for celiac patients. Drug labels are not legally required to disclose gluten content — FDA guidance on labeling has been draft and voluntary since December 2017 (Docket FDA-2017-D-6352).

Do FDA rules require manufacturers to label gluten in medications?

No. The FDA's 2017 draft guidance recommends voluntary disclosure of the phrase 'Contains no ingredient made from a gluten-containing grain (wheat, barley, or rye)' when truthful, but as of 2026 this guidance is still draft and still voluntary. Legislation to make it mandatory (Rep. Tim Ryan 2013, 2015, 2019; Sen. Blumenthal S.3021 2019) has not passed.

Do EU rules require manufacturers to label gluten in medications?

Partially. The EMA requires that when wheat starch is used as an excipient in a centrally-authorised medicinal product, the package leaflet must declare the residual gluten content in micrograms per dose. The product may only be labelled 'gluten-free' if the residual is below 20 ppm. Rules come from CHMP/704219/2013. However, only ~1,850 centrally-authorised products are covered; many mainstream prescriptions are nationally authorised through agencies like BfArM, MHRA, or AIFA and fall outside the EMA central database.

How many medications actually contain gluten?

The 2024 pediatric NDC analysis of 689 product codes across the top 100 pediatric medications found 50.2% confirmed gluten-free, 22.6% gluten-free with no cross-contamination guarantee, 25.7% could not confirm, and 1.5% (10 NDCs) actually contained gluten. The Lizano-Díez 2024 Portugal study found gluten-derived excipients in 44.4% of paracetamol analgesics — almost all in liquid pediatric formulations — versus 8.2% of ibuprofen NSAIDs and 0% of antiasthmatics.

Where does the real gluten risk live in medications?

Three places: (1) liquid and oral suspension formulations, especially pediatric — wheat starch is common as a thickener; (2) generic substitutions — generics are not required to use the same inactive ingredients as the brand, and pharmacies may switch generic manufacturers between fills without notice; (3) silent formulation changes — a manufacturer can change a carrier or excipient supplier without notifying patients, so a manufacturer attestation is point-in-time and not a warranty.

What should celiac patients do at the pharmacy?

For most adult oral pills and capsules the risk is low. For liquids, suspensions, chewables, and especially pediatric formulations: read the inactive-ingredients list, look for 'starch' without a source qualifier (wheat starch is the main concern; corn / potato / tapioca / rice starches are gluten-free), and call the manufacturer if you can't confirm. When switching from brand to generic — or from one generic manufacturer to another — re-screen the new label even if the active ingredient is identical.

A 5-minute read · April 2026

Is there gluten in your prescription?

Most prescription drugs in your medicine cabinet are gluten-free. The catch is that nobody is required to tell you that, and a small fraction of formulations genuinely do contain gluten. Here's the picture in 2026, in plain English.

The regulations: a tale of two coastlines

United States — voluntary, eight years and counting

Gluten in food has been regulated since 2014 — anything labeled "gluten-free" must contain less than 20 ppm. Drugs were specifically excluded from that rule (the Food Allergen Labeling and Consumer Protection Act of 2004 didn't cover medications). The FDA finally issued draft guidance on labeling gluten in oral drugs in December 2017 — Docket FDA-2017-D-6352. As of April 2026, eight years later, it's still draft and still voluntary. Manufacturers may add the statement "Contains no ingredient made from a gluten-containing grain (wheat, barley, or rye)" if it's truthful, but they don't have to. Bills to require disclosure (Rep. Tim Ryan in 2013, 2015, 2019; Sen. Blumenthal S.3021 in 2019) all died in committee.

European Union — mandatory, but only for some drugs

EMA has the opposite stance. When wheat starch is used as an excipient, manufacturers must declare residual gluten content in micrograms per dose, and may only call the product "gluten-free" if it's below 20 ppm. The rule comes from CHMP/704219/2013 and the EU Annex to the 2017 excipient labelling guideline. This is mandatory for centrally-authorised medicines.

The practical gap: EMA's mandatory disclosure only covers ~1,850 centrally-authorised products. Many mainstream prescriptions like atorvastatin, lisinopril, and metformin are nationally authorised through agencies like BfArM (Germany), MHRA (UK), or AIFA (Italy) and aren't in the EMA central database. So the strictest rules apply to the smallest slice of the market.

How many drugs are actually a risk?

Probably less than you'd guess.

"The vast majority of oral drug products either contain no gluten or virtually no gluten." When gluten is present at all, the FDA estimates wheat starch and other wheat-derived ingredients contribute no more than 0.5 mg per unit dose — less than what's allowed in a 30-gram serving of a food labeled gluten-free.

— FDA, "Medications and Gluten" consumer guidance

The empirical studies broadly agree:

King 2013, Hospital Pharmacy 48(9):736-43 (PubMed 24421547) surveyed manufacturers of the top 200 prescription drugs by volume. The vast majority confirmed gluten-free; the rest declined to confirm or didn't respond.
Beyond Celiac 2014 study (FDA-funded, 5,623 survey respondents) — 1,399 (25%) reported a suspected adverse reaction from gluten in medication. Of 39 drugs tested in the lab, most were below the limit of quantification.
2024 pediatric study (PMC 12172667) analyzed 689 NDCs across the top 100 pediatric medications: 50.2% confirmed gluten-free, 22.6% gluten-free with no cross-contamination guarantee, 25.7% couldn't confirm, and 1.5% (10 NDCs) actually contained gluten.
Lizano-Díez 2024 Portugal study (PMC 11958770) found gluten-derived excipients in 44.4% of paracetamol analgesics, 8.2% of ibuprofen NSAIDs, and 0% of antiasthmatics. Most of the gluten was concentrated in liquid pediatric formulations.
Our own EMA dataset — across all 1,360 parsed EU centrally-authorised leaflets, zero declare wheat starch as an excipient. EU centrally-authorised products skew toward biologics and specialised modern drugs that don't use wheat starch.

A defensible bottom-line estimate is: roughly 1–2% of common adult oral drugs in the US contain any gluten at all, and when present it's usually well below the 10 mg/day threshold that's generally considered safe for celiac patients. (The Catassi 2007 RCT showed villous worsening at 50 mg/day for 3 months; consensus is to keep daily intake under 10 mg.)

Where the risk actually lives

Three real concerns survive that statistical comfort:

Liquid and oral suspension formulations, especially pediatric. The Portugal study found 40–50% of liquid paracetamol products had gluten-derived excipients — mostly wheat starch as a thickener. If you give your kid a teaspoon of antibiotic syrup twice a day for two weeks, the cumulative dose can matter even if each milligram is small.
Generic substitution. Generics aren't required to use the same inactive ingredients as the brand. The brand may be safe and the generic may not be. The pharmacy may also switch generic manufacturers between fills without telling you.
Formulation changes. A manufacturer can change their carrier or excipient supplier without notice. A drug that tested gluten-free last year might use a wheat-derived starch this year. Manufacturer attestations are point-in-time, not warranties.

The practical advice

For most adult oral pills and capsules: low risk, low vigilance needed. For liquids, suspensions, chewables, and especially pediatric formulations: read the inactive-ingredients list, look for "starch" without a source qualifier, and call the manufacturer if you can't confirm. If you switch from brand to generic — or from one generic manufacturer to another — screen the new label even if the active ingredient is identical.

That third part — confirming a switch hasn't introduced a new risk — is exactly what this app is built to do. It cross-references U.S. labels (DailyMed), EU labels (EMA), and the curated Plogsted list to give you a quick read on whether a specific drug-and-manufacturer combination is worth a closer look.

Screen a drug →

Sources FDA "Gluten in Drug Products and Associated Labeling Recommendations" draft guidance, December 2017; FDA consumer page "Medications and Gluten"; EMA CHMP/704219/2013; King 2013, Hospital Pharmacy 48(9):736-43; Beyond Celiac 2014 FDA-funded study; Spector Cohen et al., Rambam Maimonides Medical Journal 2019; Catassi et al., Am J Clin Nutr 2007; Lizano-Díez et al., 2024; Mangione et al., 2024 (top 100 pediatric medications NDC analysis); Plogsted, glutenfreedrugs.com; empirical analysis of 1,360 EMA centrally-authorised products in this app's own dataset.